De-cancer / curatio / medicinae / leukemia

Medicamenta Approbata pro Leukemia

Haec pagina lists cancer medicinae probatus fuerit per Quod Cibus et medicamentis Administration (FDA) pro leukemia. * Ut notam album quod includit nomina. Haec pagina etiam libros communi junctiones medicamento usus est in leukemia. A iunctura pharmaca in singula sunt FDA-approbatus. Sed accumsan medicamento probatus ipsi plerumque non sunt, sed sunt late adhibetur.

Quod pharmacum est scriptor nomina NCI ad cancer summaria medicamentis Information. Medicinae non sit in leukemia sunt non enumerantur hic.

Medicamenta Approbata pro acutus Lymphoblastic Leukemia (ALL)

Arranon (Nelarabine)

Haemophilus Asparaginase chrysanthemi

Asparlas (Calaspargase Pegol, mknl)

Responsa (Inotuzumab Ozogamicin)

Blinatumomab

Blincyto (Blinatumomab)

Calaspargase Pegol mknl,

Cerubidine (Daunorubicin Hydrochloride)

Clofarabine

Clolar (Clofarabine)

cyclophosphamide

Cytarabine

Dasatinib

Daunorubicin Hydrochloride

dexamethasone

Doxorubicin Hydrochloride

Erwinaze (Asparaginase Haemophilus chrysanthemi)

Gleevec (Imatinib Mesylate)

Iclusig (Ponatinib Hydrochloride)

Inotuzumab Ozogamicin

Imatinib Mesylate

Kymriah (Tisagenlecleucel)

Marqibo (vincristine Sulfate Liposoma)

Mercaptopurine

methotrexate

Nelarabine

Oncaspar (Pegaspargase)

Pegaspargase

Ponatinib Hydrochloride

valium

Purinethol (Mercaptopurine)

Purixan (Mercaptopurine)

Rubidomycin (Daunorubicin Hydrochloride)

Sprycel (Dasatinib)

Tisagenlecleucel

Trexall (Methotrexate)

vincristine sulfas

Vincristine Liposoma sulfas

Acute Lymphoblastic Leukemia pulchra medicamento expensis (ALL)

Hyper-CVAD

Medicamenta Approbata pro acutus Myeloid Leukemia (AML)

Arsenic Trioxide

Cerubidine (Daunorubicin Hydrochloride)

cyclophosphamide

Cytarabine

Daunorubicin Hydrochloride

Daunorubicin Hydrochloride et Cytarabine Liposoma

Daurismo (Glasdegib Maleate)

dexamethasone

Doxorubicin Hydrochloride

Enasidenib Mesylate

Gemtuzumab Ozogamicin

Gilteritinib Monocotyledones

Glasdegib Maleate

Idamycin PFS (Idarubicin Hydrochloride)

Idarubicin Hydrochloride

Idhifa (Enasidenib Mesylate)

Ivosidenib

Midostaurin

Mitoxantrone Hydrochloride

Mylotarg (Gemtuzumab Ozogamicin)

Rubidomycin (Daunorubicin Hydrochloride)

Rydapt (Midostaurin)

TABULETTA (Thioguanine)

Thioguanine

Tibsovo (Ivosidenib)

Trisenox (Arsenic Trioxide)

Venclexta (Venetoclax)

Venetoclax

vincristine sulfas

Vyxeos (Daunorubicin Hydrochloride et Cytarabine Liposoma)

Xospata (Gilteritinib Monocotyledones)

Acuti pulchra medicamento expensis Myeloid Leukemia (AML)

eft ADE;

Medicamenta Approbata pro Blastic plasmacytoid dendritic Cell naturae (BPDCN)

• Elzonris (Tagraxofusp, erzs)

• Tagraxofusp erzs,

Medicamenta Approbata pro Longos lymphocytic leukemia (C.LL.)

Alemtuzumab

Arzerra (Ofatumumab)

Bendamustine Hydrochloride

Bendeka (Bendamustine Hydrochloride)

Campath (Alemtuzumab)

chlorambucil

Copiktra (Duvelisib)

cyclophosphamide

dexamethasone

Duvelisib

Fludarabine PHOSPHATE

Gazyva (Obinutuzumab)

Ibrutinib

Idelalisib

Imbruvica (Ibrutinib)

Leukeran (chlorambucil)

Mechlorethamine Hydrochloride

Mustargen (Mechlorethamine Hydrochloride)

Obinutuzumab

Ofatumumab

valium

Rituxan (Rituximab)

Rituxan Hycela (Rituximab et Humanum Hyaluronidase)

Rituximab

Et Humanum Rituximab Hyaluronidase

Treanda (Bendamustine Hydrochloride)

Venclexta (Venetoclax)

Venetoclax

Zydelig (Idelalisib)

Longos pulchra medicamento expensis lymphocytic leukemia (C.LL.)

Chlorambucil prednisone,

CVP

Medicamenta Approbata pro Longos Myelogenous Leukemia (CML)

Bosulif (Bosutinib)

Bosutinib

Busulfan

Busulfex (Busulfan)

cyclophosphamide

Cytarabine

Dasatinib

dexamethasone

Gleevec (Imatinib Mesylate)

Hydrea (Hydroxyurea)

Hydroxyurea

Iclusig (Ponatinib Hydrochloride)

Imatinib Mesylate

Mechlorethamine Hydrochloride

Mustargen (Mechlorethamine Hydrochloride)

Myleran (Busulfan)

Nilotinib

Omacetaxine Mepesuccinate

Ponatinib Hydrochloride

Sprycel (Dasatinib)

Synribo (Omacetaxine Mepesuccinate)

Tasigna (Nilotinib)

Medicamenta probatum est Pilosus Cell Leukemia

Cladribine

A Intrón (recombinante Interferón alfa-2a)

Lumoxiti (Moxetumomab Pasudotox, tdfk)

Moxetumomab Pasudotox tdfk,

Recombinante alfa-2a Interferón

Medicamenta Approbata pro Matrix Leukemia

Midostaurin

Rydapt (Midostaurin)

Medicamenta Approbata pro Meningeal Leukemia

Cytarabine